A critical care nurse friend mentioned to me that an article in the December issue, “Rhabdomyolysis: Pathophysiology, Recognition, and Management” (December 2003:14–32), was on the topic of rhabdomyolysis, which we had discussed recently in reference to management of patients who had been using “Ecstasy.” In the article, the author identifies “Ecstasy” as N-methyl-D-aspartate (NDMA). Although street drugs vary in purity, and many times customers get an unknown substance instead of the drug they believe they have purchased, in substance abuse and medical literature, the chemical usually identified by the street name of “Ecstasy” is 3,4-Methylenedioxy-methamphetamine (MDMA). MDA, 3,4-Methylenedioxyamphetamine, is also sometimes called “Ecstasy” or “the Love Drug.”
Skip Nav Destination
Article navigation
1 April 2004
Departments|
April 01 2004
Ecstasy substance abuse
Carole E. Nowicke, PhD, MLS
Carole E. Nowicke, PhD, MLS
Bloomington, Ind
Search for other works by this author on:
Crit Care Nurse (2004) 24 (2): 16.
Citation
Carole E. Nowicke; Ecstasy substance abuse. Crit Care Nurse 1 April 2004; 24 (2): 16. doi: https://doi.org/10.4037/ccn2004.24.2.16-a
Download citation file:
Sign in
Don't already have an account? Register
Short-term Access
Purchase short-term access on a pay-per-article or pay-per-issue basis.
$15 72 - hour single article access $30 7 - day full issue access